Topic Highlight
Copyright ©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Oct 14, 2014; 20(38): 13741-13755
Published online Oct 14, 2014. doi: 10.3748/wjg.v20.i38.13741
Table 5 Clinical trials of everolimus
PatientsPhaseTreatmentnOS (mo)PFS (mo)RRDCR
Previously treated metastatic gastric cancerIIEverolimus5310.12.70%54.7%
Second-line treatment for advanced gastric cancer (GRANITE-1)IIIPlacebo2174.341.412.1%N/A
Everolimus4395.391.684.5%N/A